We report two cases in which Cryptococcus laurentii was isolated from surgically resected pulmonary lesions but the cryptococcal cells in tissue reacted positively with a specific fluorescent antibody (FA) conjugate for Cryptococcus neoformans. Both patients had no apparent host defense defects. In both cases, multiple cryptococcal isolates were obtained from tissue, and yeastlike cells consistent with C. neoformans were seen in direct histology. The isolates were identified by assimilation patterns and standard procedures including phenoloxidase reactions. Since C. laurentii was consistently isolated by using stringent procedures, it was considered unlikely that the fungus represented surgical or laboratory contamination. Its presence may be the result of dual infection not detected by FA, but other possible explanations exist. The results show the value of the FA test in diagnostic mycology and call into question previous reports of cryptococci other than C. neoformans as agents of infection.
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There have been numerous reports over the years of Cryptococcus species other than C. neoformans causing human infection (Table 1) . Isolates in these cases have most often been obtained from body sites which characteristically have been associated with C. neoformans infection. For example, in 6 of 12 published cases, isolates were obtained from cerebrospinal fluid (Table 1 ) while in 3 other cases, non-C. neoformans isolates were recovered from pulmonary sources. In 11 of the 12 cases, the species isolated was either C. albidus or C. Iaurentii, both of which are commonly isolated from normal skin (14, 17) and indoor and outdoor air (20, 31) .
Recently, we investigated two cases strongly suggestive of pulmonary infection by C. laurentii. In both instances, while multiple isolates of C. laurentii were obtained from surgically resected lung tissue, C. neoformans was not isolated. Fluorescent antibody staining (FA) techniques, however, indicated that the fungus present in the tissues was C. neoformans. These unusual findings suggest that a reassessment of the literature with respect to infections supposedly caused by Cryptococcus species other than C. neoformans is in order and that the clinical ecology of such infections requires clarification. Microscopic studies of stained preparations of a portion of tissue removed on biopsy revealed small numbers of widely scattered budding yeastlike cells consistent with Cryptococcus spp. Culture media inoculated with a portion of the same tissue yielded numerous colonies of a yeastlike organism tentatively identified as C. albidus. However, upon extensive investigation the organism was found to be C. laurentii (Table 2) . A representative isolate was deposited in the University of Alberta Microfungus Collection and Herbarium as UAMH 6255.
Sections stained with specific anti-C. neoformans fluorescein-tagged antibody showed that the tissue contained widely scattered, brightly fluorescing individual cells and clusters of yeastlike cells consistent with C. neoformans or a closely related, cross-reacting Cryptococcus species. After absorption of the conjugate with C. laurentii antigen, the cells continued to fluoresce, indicating that they were not C. laurentii. Cells also reacted positively to anti-C. neoformans conjugate absorbed with C. albidus antigens, indicating they were not C. albidus. On the basis of consistent reaction with these well-controlled, highly specific conjugates, the yeastlike cells were recognized as C. neoformans.
The patient was treated with amphotericin B (0.3 mg/kg! day for 4 weeks) and 5-fluorocytosine (75 mg/kg/day divided over four daily doses for 4 weeks). Four years after treatment was completed, the patient was in good health. He was described as aymptomatic, but a chest X-ray revealed a persistent right-lobe pneumonic process. Sputum and skin tests for tuberculosis and coccidioidomycosis were negative. Routine laboratory tests were all within normal limits. A fiber-optic bronchoscopy was performed and did not reveal any abnormalities. Cultures and smears of bronchial brushings and washings were negative. Because the lesion seen in the X-ray was suspected to be a malignancy, a thoracotomy was performed. A large mass in the middle lobe and a smaller mass in the right lower lobe were observed and biopsied. Histopathology with periodic acid-Schiff (24), Grocott methenamine silver (24) , and hematoxylin and eosin (19) stains was initially viewed as being consistent with histoplasmosis, since small cells were seen and some were interpreted as being within macrophages. Surgery was performed to remove the masses, and histopathology of the resected material with mucicarmine stain (24) revealed the presence of a cluster of large budding yeasts suggestive of a cryptococcal fungus ball. Samples of lung material plated on Sabouraud peptone-dextrose agar yielded multiple cultures of C. laurentii var. laurentii. The identification was confirmed by two independent reference laboratories on the basis of characteristic morphological and physiological attributes (Table 2 ). Upon confirmation of this identification, a preliminary report on the case was presented indicating a diagnosis of C. laurentii pneumonia (30) . Subsequent FA studies done independently at two laboratories indicated that the organisms seen in tissue were C. neoformans var. neoformans. Cross-absorption studies with C. laurentii antigens confirmed this identification.
The patient was not treated with antifungal drugs and did well. At a 3-year follow-up he had no evidence of progressive or active disease.
MATERIALS AND METHODS
Lung tissues were ground in sterile glass mortars in physiological saline, and 2 drops (approx. 60 ,ul) of a heavy suspension was spread by means of a sterile loop on each of several routine fungal isolation media: bovine blood agar; Sabouraud glucose agar with 100 ,ug of cycloheximide per ml, 100 ,ug of chloramphenicol per ml, and 50 jig of gentamicin per ml; and Littman's oxgall agar (Difco Laboratories, Detroit, Mich.) with 100 ,ug of streptomycin per ml. Plates were incubated at 25°C for up to 3 weeks. Yeast colonies which became apparent during that time were subcultured from isolation media to Sabouraud glucose agar with 100 ,ug of chloramphenicol per ml and 50 ,ug of gentamicin per ml only and then examined microscopically for morphological features. In addition, isolates were subjected to assimilation auxanography and fermentation tests by using the techniques outlined by Kreger-van Rij (10) . Isolates obtained were also subcultured to Staib agar (Guizotia abyssinicabased phenoloxidase test agar) for detection of the brown reaction typical of C. neoformans (13, 26) .
Sections of lung tissue stained with mucicarmine and Grocott methenamine silver (24) were examined for the presence of fungal cells. For FA (7) studies, paraffin-em- cold water and attached to glass slides with dilute commercial Elmer's Glue-All (7) . Mounted sections were then directly stained with specific rabbit anti-C. neoformans fluorescein isothiocyanate (7 (5, 12) , the identification of the isolates recovered is either questionable or at least not verifiable from published data. In Table 3 , the cryptococcal isolates noted in Table 1 are again listed along with information pertinent to the confirmation of their pathogenic status and identification.
In only 5 of the 12 cases listed in Table 3 (3, 11, 12) it was recovered from normally contaminated sources such as sputum (3, 11, 12) , bronchial wash (11) , and gastric lavage (11) . The diagnosis of one fungemia case with nonspecific symptoms was based solely on a single positive blood culture and the positive response of the patient to amphotericin B therapy (5) .
In one case (25) where the fungus is listed in Table 3 as being from a normally sterile site, this site is in fact an unusually vulnerable one: the peritoneal fluid of a patient with a Tenckhoff catheter. In another case involving a normally sterile site, Cryptococcus colonies were obtained from subcutaneous tissue of a patient with an infection resembling Madura foot (8) . In this case, an unclassified isolate resembling an atypical mycobacterium was also recovered and the patient responded to antibacterial and antimycobacterial agents (8) . In the remaining three cases in which the fungus was repeatedly isolated (4, 29 [2 cases]), the normally sterile site was cerebrospinal fluid. In three cases (5, 12, 15) , negative results with slide latex agglutination tests for C. neoformans diffusible antigen were reported for cases diagnosed as non-C. neoformans cryptococcosis. In none of these cases, however, were Cryptococcus-like cells found in the cerebrospinal fluid (12, 15) or serum (5) assayed. Hence the substantiation of any cryptococcal colonization whatsoever in these cases is weak. Wieser (29) , using the antibody detection techniques of Vogel et al. (28) , demonstrated the presence of antibodies in cerebrospinal fluid which reacted with C. albidus antigen even after prior absorption with a C. neoformans homogenate. The titer of the reaction was much lower after absorption with C. neoformans than before. Wieser did not state, however, whether the homogenate used for absorption included all serotypes of C. neoformans. Thus, it remains uncertain that the diminished quantity of reactive antibodies remaining after absorption were truly specific to C. albidus.
The identification of many of the cryptococcal isolates listed in Tables 1 and 3 is also problematic. The putative C. luteolus reported by Binder et al. (3) grew abundantly at 37°C. Yet, recent taxonomic texts (1, 23) , indicate this species cannot grow at this elevated temperature. Using the characters described by Binder et al. (3) and the taxonomic keys of Rodrigues de Miranda (23), we tentatively identified the isolates as C. neoformans. However, the isolates recovered by Binder et al. (3) were atypical of C. neoformans in that colonies were yellowish-brown, cells were ellipsoidal in shape, and the fungus was not pathogenic in an experimental mouse model. Doubts as to the identity of the C. albidus isolated from lung by Krumholz (11) have already been summarized by Gordon (6) . 
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The remaining identifications listed in Table 1 (6) has pointed out, however, "a single negative virulence test does not exclude C. neoformans"; moreover, a few C. neoformans isolates are known to have weak encapsulation (21) and weak growth at 37°C in vitro (1) . Unfortunately, there is no record of any isolate from a putative case of non-C. neoformans cryptococcosis being deposited in a recognized fungal culture collection. Hence the taxonomic reliability of such reports cannot be independently confirmed by the reexamination of isolates.
Despite these problems, at least two of the reported cases of non-C. neoformans cryptococcosis, i.e., the case described by Kamalam et al. (8) and the primary case reported by Wieser (29) , amass sufficient anomalous information that it would be difficult to reinterpret them as misconstrued cases of infection caused by C. neoformans or another yeast. These cases include a tissue demonstration of cryptococcal cells, a repeat culture from a normally sterile site, and an extensive effort to achieve a correct identification in consultation with independent reference laboratories. On the other hand, our own cases would be equally difficult to interpret as C. neoformans infection if not for the direct evidence of FA. Therefore, all existing reports of non-C. neoformans cryptococcosis must be regarded as questionable until a direct and unequivocal demonstration of non-C. neoformans cryptococcal cells in tissue is made.
The circumstantial evidence for non-C. neoformans cryptococcal infection in our cases and similar instances requires some explanation. Certainly the isolation of non-C. neoformans cryptococci from percutaneous samples such as blood and lumbar punctures may be at least partly explained by the very common presence of these organisms as contaminants of normal skin (14, 17) . The occasional fortuitous isolation of these fungi in blood cultures is well documented (2, 22) . Limited colonization around catheterization sites may also be expected. In such cases, the isolation of cryptococcal contaminants may coincide with infection by other, unrecovered fungi. However, none of these factors related to skin colonization affect the interpretation of pulmonary infections supposedly caused by cryptococci other than C. neoformOns.
The isolation of significant numbers of non-C. neoformans cryptococci from C. neoformans infections may be tentatively explained in a number of ways, none of which can be definitively substantiated. Simple laboratory contamination mnust be ruled out in our cases, as growth of the non-C. neoformans yeasts was consistent in repeat samples, occurred only from sample materials (not, for example, on areas not touched by the loop in streaked agar plates), and was of an intensity uncharacteristic of aerial contamination. Also, although non-C. neoformans cryptococci are generally among the most common airborne contaminants in normal indoor and outdoor air (20, 31) , they are uncommon in the clinical laboratories involved in this study, which possess modern filtered air systems. A year-round survey of fungi isolated from air in the hospital where our case no. 1 was observed showed that C. laurentii accounted for only 3 While we cannot provide a definite explanation of our findings, we hope that future studies will shed additional light on possible infections by non-C. neoformans cryptococci and on the potential diagnostic problems caused by naturally occurring yeast contaminants in pulmonary specimens. In the interim, our results suggest that FA studies should be employed in assessing the etiology of pulmonary and other infections which would appear to be caused by cryptococci other than C. neoformans.
